StockDrifts LogoStockDrifts

Latest SEC filings

Every 8-K, 10-Q, 10-K, Form 4 and 13D/G as it is filed, each one read and summarised so you can see what actually happened without opening the document.

Filing type

10-K
10-Q
8-K
6-K
Form 4
13D
13G
S-1

Event

Earnings
Guidance
M&A
Executive change
Insider trade
Equity offering
Buybacks & dividends
Index inclusion
Regulatory & legal

Chief Executive Officer John T Hall exercised 3,000 options at $7.45 and sold the same 3,000 shares at $37.93 for $113,795.40, under a pre-arranged 10b5-1 plan.

  • Sale was a same-day cashless exercise-and-sell: 3,000 Employee Stock Options exercised at $7.45, immediately disposed at $37.93.
  • Total transaction value $113,795.40 at a realised sale price of $37.93 per share.
Neutral
Read the filing →

Bilibili granted 4,580,801 RSUs on September 16, 2026, about 1.09% of shares in issue, with nil purchase price and vesting between 2027 and 2032.

  • Aggregate grant of 4,580,801 RSUs: 4,565,768 to employees and 15,033 to Service Providers, under the Second Amended and Restated 2018 Share Incentive Plan.
  • No performance targets attached; vesting runs from September 16, 2027 to September 16, 2032; clawback provisions apply.
Neutral
Read the filing →
DNA
4
Sell

Ginkgo Bioworks Holdings, Inc.

Director Christian O Henry sells 5,000 shares for $35,405

Director Christian O Henry sold 5,000 Class A shares at $7.08 for $35,405 in an open-market transaction not made under a 10b5-1 plan.

  • Sale of 5,000 Class A shares at $7.08, dated 09/15/2026 and signed 09/16/2026.
  • The transaction was not made under a Rule 10b5-1 trading plan.
Neutral
Read the filing →
NVT
8-K

nVent Electric plc

Prices $800M of 6.150% senior notes due 2036

nVent subsidiary Hoffman Schroff agreed to sell $800.0 million of 6.150% senior notes due 2036 in a public offering, guaranteed by nVent and nVent Finance.

  • $800.0 million aggregate principal amount of 6.150% Senior Notes due 2036 sold by Hoffman Schroff Holdings, Inc.
  • Notes are fully, unconditionally and jointly and severally guaranteed by nVent Electric plc and nVent Finance S.à r.l.
Neutral
Read the filing →

Doximity Chief Accounting Officer Siddharth Sitaram sold 2,077 Class A shares at $26.02 for $54,043.54 under a pre-arranged 10b5-1 plan, after exercising options and converting Class B stock.

  • Sale executed at $26.02 per share on 09/15/2026, a total of $54,043.54 for 2,077 Class A shares.
  • Transaction was made under a pre-arranged Rule 10b5-1 plan, so it was scheduled rather than discretionary.
Neutral
Read the filing →

onsemi's investor-day deck reiterates its pending acquisition of Synaptics, disclosing $200M of synergies and post-deal targets of over 55% gross and 30% operating margin.

  • onsemi targets $200M of synergies from the Synaptics transaction, accretive to EPS within roughly 18 months
  • Synaptics standalone operating margin is put at over 15%, rising to over 30% post-synergies, with gross margin above 55%
Neutral
Read the filing →

Veeva President and Chief Customer Officer Thomas D. Schwenger sold 1,000 Class A shares at $265.20 for $265,200 under a pre-arranged 10b5-1 plan, leaving him 18,449 shares.

  • Sale of 1,000 Class A shares at $265.20 on 09/14/2026, total value $265,200
  • Transaction was made under a pre-arranged Rule 10b5-1 trading plan
Neutral
Read the filing →

Ethos said a July 2026 service disruption at carrier partner TruStage did not breach its own systems or materially affect Q3 2026 results, with any impact already reflected in its August 3 guidance.

  • No Ethos systems were penetrated and no data was exfiltrated from the Company's systems as a result of the TruStage incident.
  • Ethos does not expect any material impact on Q3 2026 financials; any impact was already factored into the Q3 2026 guidance issued on August 3, 2026.
Neutral
Read the filing →

Awarded a five-year Government of Canada contract to supply tactical ISR uncrewed aircraft systems to the Canadian Armed Forces, with a firm 100-system order and options for 4,900 more valued at about C$24.25 million.

  • Initial firm commitment is for 100 Low-Cost Tactical ISR UAS plus ground control stations, payloads, data links, support equipment, documentation, spare parts and training; pricing for those systems is commercially sensitive and was not disclosed.
  • Canada retains the right, at its sole discretion, to order up to 4,900 additional systems; if all options were exercised the total would be 5,000 systems, with the option package valued at approximately C$24.25 million, exercisable only by written contract authorisation or amendment.
Bullish
Read the filing →

Baidu bought back 556,100 Class A ordinary shares on the Hong Kong exchange on 15 September 2026 at HKD 88.90-90.95, paying HKD 49,998,283.68.

  • Cumulative repurchases under the mandate granted 26 August 2026 now total 3,870,750 shares, or 0.142% of issued shares as at the resolution date.
  • The mandate authorises up to 273,356,149 shares; the 15 September purchase was made on the Exchange at a volume-weighted average of HKD 89.9088.
Neutral
Read the filing →

Karman furnished an investor presentation disclosing record backlog of $1,322M as of June 30, 2026 and ~1.6x book-to-bill over the last 18 months.

  • Backlog reached a record $1,322M as of June 30, 2026, up ~$398M (~69%) from $580M at Q4 2024 excluding acquired backlog
  • Book-to-bill of ~1.6x over the last 18 months versus the ~1.2-1.3x target set at IPO; organic growth of 25%+ versus ~18% promised
Bullish
Read the filing →

Phoenix Financial Ltd. reported beneficial ownership of 2,746,913 Nova ordinary shares, or 8.64% of the class, alongside a 5.88% stake held by Partnership for Israeli shares.

  • Phoenix Financial Ltd. reports 2,746,913.24 ordinary shares, equal to 8.64% of the class, all with shared voting and dispositive power.
  • Partnership for Israeli shares separately reports 1,867,585.28 shares, or 5.88%, with all ownership rights belonging to Phoenix Group companies.
Neutral
Read the filing →

At its 2026 Investor Day, Oscar Health raised full-year 2026 earnings from operations guidance by $100 million and improved its medical loss ratio outlook by 50 basis points, while reaffirming revenue.

  • Earnings from Operations guidance raised to $600M-$800M from $500M-$700M, a $100M increase at both ends of the range.
  • Medical Loss Ratio guidance improved to 81.0%-82.0% from 81.5%-82.5%, a 50 basis point improvement.
Bullish
Read the filing →
RIVN
4
Sell

Rivian Automotive, Inc. / DE

Chief Administrative Officer sells 15,000 shares for $244,391

Rivian Chief Administrative Officer Michael John Callahan sold 15,000 Class A shares at $16.29 for $244,390.50 under a pre-arranged 10b5-1 plan.

  • Sale of 15,000 Class A shares at $16.29, a total of $244,390.50, executed 09/11/2026.
  • Transaction was made under a pre-arranged Rule 10b5-1 trading plan, so it was scheduled rather than discretionary.
Neutral
Read the filing →

ProFrac GDM moved 1,319,493 Flotek shares to THRC Holdings and 987,313 to Farris C. Wilks, who cancelled $60,000,000 of Alpine Holdings term loans in exchange.

  • Aggregate ProFrac beneficial ownership is unchanged at 20,937,915 shares, or 54.5% of the 36,220,429 shares outstanding as of August 3, 2026.
  • ProFrac GDM exercised its April 28, 2025 warrant on March 13, 2026, receiving 6,000,000 shares; after the transfers it holds 3,693,194 shares, or 10.2%.
Neutral
Read the filing →
MRVL
4
Sell

Marvell Technology, Inc.

CEO Matthew Murphy sells $1.68M of stock under 10b5-1 plan

Chairman and CEO Matthew J Murphy sold 7,500 Marvell shares at $223.39 for $1,675,425 under a pre-arranged 10b5-1 trading plan, leaving him 775,686 shares.

  • Sale of 7,500 common shares at $223.39 on 09/15/2026, transaction code S (open-market disposal).
  • Total transaction value $1,675,425; the filing reports a single line, not multiple tranches.
Neutral
Read the filing →
FTK
4
Buy

FLOTEK INDUSTRIES INC/CN/

Director Matthew Wilks buys 1,319,493 shares for $34.3M

Director Matthew Wilks purchased 1,319,493 common shares at $26.01, a $34,320,013 open-market buy, raising his indirect holdings to 1,477,285 shares.

  • Transaction code P: open-market purchase, not an option exercise or grant
  • Price of $26.01 per share on 09/11/2026
Bullish
Read the filing →
FTK
4
Sell

FLOTEK INDUSTRIES INC/CN/

10% owner ProFrac GDM sells $60M of stock

ProFrac GDM, LLC, a 10% holder, sold 2,306,806 shares of Flotek at $26.01 for $60,000,024, cutting its position to 3,693,194 shares.

  • Sale covered 2,306,806 shares at $26.01 per share, a total of $60,000,024.06.
  • The reporting owner is ProFrac GDM, LLC, listed as a 10% owner, not an officer or director of the issuer.
Bearish
Read the filing →

Qualys CEO and President Sumedh S. Thakar sold 3,200 common shares for $544,152 in an open-market transaction executed under a pre-arranged 10b5-1 trading plan.

  • Sale executed 09/14/2026 across ten tranches at prices from $154.39 to $174.71 per share.
  • Thakar retains 180,338 shares directly owned following the transaction.
Neutral
Read the filing →
CCXI
425

Churchill Capital Corp XI

Merger target Agility Robotics unveils Digit 5 humanoid

Agility Robotics, the target of Churchill Capital Corp XI's pending SPAC merger, unveiled its Digit 5 humanoid robot with new legs, batteries and a safety architecture allowing work near people.

  • Digit 5 lifts up to 50 lb (22.7 kg) and reaches 7.2 ft, up from Digit 4's 5.5 ft; it weighs 284 lb (129 kg) and runs 90 minutes on a nine-minute full charge, a 10:1 run-to-charge ratio versus Digit 4's 2:1.
  • Agility cites more than $300 million in multi-year orders; the article notes Agility generated $1.8 million in net sales in 2025.
Neutral
Read the filing →

Companies on this page